MGTX
Price
$5.06
Change
-$0.24 (-4.53%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
442.01M
77 days until earnings call
ZLAB
Price
$32.52
Change
-$0.07 (-0.21%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
3.56B
80 days until earnings call
Interact to see
Advertisement

MGTX vs ZLAB

Header iconMGTX vs ZLAB Comparison
Open Charts MGTX vs ZLABBanner chart's image
MeiraGTx Holdings
Price$5.06
Change-$0.24 (-4.53%)
Volume$10.76K
Capitalization442.01M
Zai Lab
Price$32.52
Change-$0.07 (-0.21%)
Volume$7.76K
Capitalization3.56B
MGTX vs ZLAB Comparison Chart
Loading...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MGTX vs. ZLAB commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGTX is a Hold and ZLAB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (MGTX: $5.30 vs. ZLAB: $32.59)
Brand notoriety: MGTX and ZLAB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGTX: 63% vs. ZLAB: 67%
Market capitalization -- MGTX: $442.01M vs. ZLAB: $3.56B
MGTX [@Biotechnology] is valued at $442.01M. ZLAB’s [@Biotechnology] market capitalization is $3.56B. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGTX’s FA Score shows that 0 FA rating(s) are green whileZLAB’s FA Score has 0 green FA rating(s).

  • MGTX’s FA Score: 0 green, 5 red.
  • ZLAB’s FA Score: 0 green, 5 red.
According to our system of comparison, ZLAB is a better buy in the long-term than MGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGTX’s TA Score shows that 4 TA indicator(s) are bullish while ZLAB’s TA Score has 4 bullish TA indicator(s).

  • MGTX’s TA Score: 4 bullish, 6 bearish.
  • ZLAB’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, ZLAB is a better buy in the short-term than MGTX.

Price Growth

MGTX (@Biotechnology) experienced а +14.35% price change this week, while ZLAB (@Biotechnology) price change was +15.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.82%. For the same industry, the average monthly price growth was +7.45%, and the average quarterly price growth was -1.67%.

Reported Earning Dates

MGTX is expected to report earnings on Aug 07, 2025.

ZLAB is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZLAB($3.56B) has a higher market cap than MGTX($442M). ZLAB YTD gains are higher at: 24.437 vs. MGTX (-12.972). MGTX has higher annual earnings (EBITDA): -121.84M vs. ZLAB (-236.44M). ZLAB has more cash in the bank: 757M vs. MGTX (104M). MGTX has less debt than ZLAB: MGTX (84.8M) vs ZLAB (192M). ZLAB has higher revenues than MGTX: ZLAB (418M) vs MGTX (33.3M).
MGTXZLABMGTX / ZLAB
Capitalization442M3.56B12%
EBITDA-121.84M-236.44M52%
Gain YTD-12.97224.437-53%
P/E RatioN/AN/A-
Revenue33.3M418M8%
Total Cash104M757M14%
Total Debt84.8M192M44%
FUNDAMENTALS RATINGS
MGTX vs ZLAB: Fundamental Ratings
MGTX
ZLAB
OUTLOOK RATING
1..100
587
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
49
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6140
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZLAB's Valuation (49) in the Biotechnology industry is in the same range as MGTX (71). This means that ZLAB’s stock grew similarly to MGTX’s over the last 12 months.

ZLAB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MGTX (100). This means that ZLAB’s stock grew similarly to MGTX’s over the last 12 months.

ZLAB's SMR Rating (100) in the Biotechnology industry is in the same range as MGTX (100). This means that ZLAB’s stock grew similarly to MGTX’s over the last 12 months.

ZLAB's Price Growth Rating (40) in the Biotechnology industry is in the same range as MGTX (61). This means that ZLAB’s stock grew similarly to MGTX’s over the last 12 months.

ZLAB's P/E Growth Rating (100) in the Biotechnology industry is in the same range as MGTX (100). This means that ZLAB’s stock grew similarly to MGTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MGTXZLAB
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 9 days ago
84%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FPHAX23.81N/A
N/A
Fidelity Select Pharmaceuticals Port
ABVYX17.08N/A
N/A
AB Large Cap Value Advisor
DVZRX68.97N/A
N/A
Macquarie Small Cap Value R6
LFGCX34.51N/A
N/A
Lord Abbett Focused Growth C
RLEFX34.85-0.39
-1.11%
American Funds American Balanced R5E

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with RGNX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
-3.64%
RGNX - MGTX
49%
Loosely correlated
-3.60%
KRRO - MGTX
48%
Loosely correlated
-8.53%
IDYA - MGTX
47%
Loosely correlated
-2.45%
AURA - MGTX
46%
Loosely correlated
+0.51%
NTLA - MGTX
46%
Loosely correlated
-4.86%
More

ZLAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZLAB has been loosely correlated with ONC. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ZLAB jumps, then ONC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZLAB
1D Price
Change %
ZLAB100%
-0.12%
ONC - ZLAB
54%
Loosely correlated
-0.16%
VERV - ZLAB
36%
Loosely correlated
-8.24%
MGTX - ZLAB
36%
Loosely correlated
-3.64%
PRME - ZLAB
35%
Loosely correlated
-0.85%
ZYME - ZLAB
34%
Loosely correlated
-3.94%
More